Kiemeney LA - Search Results

1

Polymorphisms in the E-cadherin (CDH1) gene promoter and the risk of bladder cancer.

Kiemeney LA, van Houwelingen KP, Bogaerts M, Witjes JA, Swinkels DW, den Heijer M, Franke B, Schalken JA, Verhaegh GW. Kiemeney LA, et al. Eur J Cancer. 2006 Dec;42(18):3219-27. doi: 10.1016/j.ejca.2006.05.033. Epub 2006 Aug 28. Eur J Cancer. 2006. PMID: 16934975

2

DD3(PCA3), a very sensitive and specific marker to detect prostate tumors.

de Kok JB, Verhaegh GW, Roelofs RW, Hessels D, Kiemeney LA, Aalders TW, Swinkels DW, Schalken JA. de Kok JB, et al. Among authors: kiemeney la. Cancer Res. 2002 May 1;62(9):2695-8. Cancer Res. 2002. PMID: 11980670

3

Single-nucleotide polymorphism in the E-cadherin gene promoter modifies the risk of prostate cancer.

Verhage BA, van Houwelingen K, Ruijter TE, Kiemeney LA, Schalken JA. Verhage BA, et al. Among authors: kiemeney la. Int J Cancer. 2002 Aug 20;100(6):683-5. doi: 10.1002/ijc.10541. Int J Cancer. 2002. PMID: 12209606

4

Allelic imbalance in hereditary and sporadic prostate cancer.

Verhage BA, van Houwelingen K, Ruijter TE, Kiemeney LA, Schalken JA. Verhage BA, et al. Among authors: kiemeney la. Prostate. 2003 Jan 1;54(1):50-7. doi: 10.1002/pros.10148. Prostate. 2003. PMID: 12481255

5

DD3(PCA3)-based molecular urine analysis for the diagnosis of prostate cancer.

Hessels D, Klein Gunnewiek JM, van Oort I, Karthaus HF, van Leenders GJ, van Balken B, Kiemeney LA, Witjes JA, Schalken JA. Hessels D, et al. Among authors: kiemeney la. Eur Urol. 2003 Jul;44(1):8-15; discussion 15-6. doi: 10.1016/s0302-2838(03)00201-x. Eur Urol. 2003. PMID: 12814669

6

Survivin mRNA copy number in bladder washings predicts tumor recurrence in patients with superficial urothelial cell carcinomas.

Schultz IJ, Kiemeney LA, Karthaus HF, Witjes JA, Willems JL, Swinkels DW, Gunnewiek JM, de Kok JB. Schultz IJ, et al. Among authors: kiemeney la. Clin Chem. 2004 Aug;50(8):1425-8. doi: 10.1373/clinchem.2004.032003. Clin Chem. 2004. PMID: 15277352 Free article. No abstract available.

7

CDC91L1 (PIG-U) mRNA expression in urothelial cell carcinomas.

Schultz IJ, Kiemeney LA, Witjes JA, Schalken JA, Willems JL, Swinkels DW, de Kok JB. Schultz IJ, et al. Among authors: kiemeney la. Int J Cancer. 2005 Aug 20;116(2):282-4. doi: 10.1002/ijc.21040. Int J Cancer. 2005. PMID: 15800923

8

The efficacy of different follow-up strategies in clinical stage I Non-seminomatous Germ Cell Cancer: a Markov simulation study.

Spermon JR, Hoffmann AL, Horenblas S, Verbeek AL, Witjes JA, Kiemeney LA. Spermon JR, et al. Among authors: kiemeney la. Eur Urol. 2005 Aug;48(2):258-67; discussion 267-8. doi: 10.1016/j.eururo.2005.04.021. Eur Urol. 2005. PMID: 15964134

9

No evidence for large-scale germline genomic aberrations in hereditary bladder cancer patients with high-resolution array-based comparative genomic hybridization.

Kiemeney LA, Kuiper RP, Pfundt R, van Reijmersdal S, Schoenberg MP, Aben KK, Niermeijer MF, Witjes JA, Schoenmakers EF. Kiemeney LA, et al. Cancer Epidemiol Biomarkers Prev. 2006 Jan;15(1):180-3. doi: 10.1158/1055-9965.EPI-05-0714. Cancer Epidemiol Biomarkers Prev. 2006. PMID: 16434610 Free article. No abstract available.

10

Prediction of recurrence in Ta urothelial cell carcinoma by real-time quantitative PCR analysis: a microarray validation study.

Schultz IJ, Wester K, Straatman H, Kiemeney LA, Babjuk M, Mares J, Willems JL, Swinkels DW, Witjes JA, de Kok JB, Malmström PU. Schultz IJ, et al. Among authors: kiemeney la. Int J Cancer. 2006 Oct 15;119(8):1915-9. doi: 10.1002/ijc.22059. Int J Cancer. 2006. PMID: 16721812

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

700 results

Search Page

Filters